Vaccine Preventable Diseases - SP Flashcards

1
Q

Infectious Disease in Global Health

A
  • Single most important contributors to human morbidity and mortality throughout history
  • Mortality has declined over past 150 years in high-income countries
  • In low- and middle-income countries they remain issues of significance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Role of poverty

A
  • Malnutrition and micronutrient deficiencies associated with increased risk of sever morbidity and mortality
  • Lack of education
  • Poor access to clean drinking water
  • Inability to dispose properly of human waste
  • Household crowding
  • Lack of access to health care
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Strategies to control infectious diseases

A
  • Vector control (malaria, dengue, yellow fever, and onchocerciasis)
  • Vaccinations (smallpox, measles, polio, neonatal tetanus, diphtheria, pertussis, tetanus, hepatitis B, meningococcal meningitis and yellow fever, human papilloma virus)
  • Mass chemotherapy (some parasites)
  • Improved sanitation and access to clean water(diarrheal diseases)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Control

A
  • Reduction of disease incidence, prevalence, morbidity or mortality to a locally acceptable level as a result of deliberate efforts;
  • Continued intervention measures are required to maintain the reduction
  • Malaria
  • Neonatal tetanus
  • Cholera
  • TB
  • Schistosomiasis
  • Diarrheal disease
  • ARI
  • AIDS
  • STIs
  • Leprosy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Elimination of disease

A
  • Reduction to zero of the incidence of a specified disease in a defined geographic area as a result of deliberate efforts;
  • Continued intervention measures are required
  • Rabies
  • Trachoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Elimination of infection

A
  • Reduction to zero of the incidence of infection caused by a specific agent in a defined geographic area as a result of deliberate efforts;
  • Continued measures to prevent reestablishment of transmission are required
  • River blindness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Eradication

A
  • Permanent reduction to zero of a worldwide incidence of infection caused by a specific agent as a result of deliberate efforts;
  • Intervention measures are no longer needed
  • Polio
  • Measles
  • Guinea worm
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Extinction

A
  • The specific infectious agent no longer exists in nature or in the laboratory
  • Extinction of smallpox is possible, although concerns about use in bioterrorism prevent destruction of the last known stocks of the virus
  • Smallpox
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Poliomyelitis

A
  • 3 known serotypes (1, 2, and 3)
  • Fecal-oral transmission
  • Ingestion of virus leads to asymptomatic or mild, self-limiting infection and shedding of virus from throat to GI tract in most persons
  • 1/100 to 1/850 develop symptomatic polio with or without paralysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Symptomatic Poliomyelitis

A

-Primarily affects 1 or both legs
-Of those developing paralysis:
~10% die acutely
~10%-15% permanently unable to walk
~10%-15% unable to walk normally

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Poliomyelitis: Initial symptoms

A
  • Fever
  • Fatigue
  • Headache
  • Vomiting
  • Stiffness in neck
  • Pain in limbs
  • Paralysis (can cause total paralysis in a matter of hours)
  • 5%-10% die due to respiratory paralysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Poliomyelitis: Epidemiology

A
  • Mainly affects children under 5 years of age
  • One in 200 infections leads to irreversible paralysis
  • Cases decreased by over 99% since 1988
  • 223 cases globally in 2012
  • 2013 only 3 countries polio endemic: Afghanistan, Nigeria, Pakistan
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Poliomyelitis: Tx

A
  • No cure
  • Treatment entirely supportive
  • Can only be prevented through multiple vaccination (series of 3) providing life-time protection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Polio Immunizations

A

Killed injectable polio vaccine (IPV)

Live oral polio vaccine (OPV)

  • Available since 1960s
  • Extremely low cost ($0.02- $0.11/dose)
  • Ease of administration
  • Intestinal induced immunity prevents oral-fecal transmission
  • Lower immunity in low- and middle-income countries
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Measles

A
  • Caused by virus in the paramyxovirus family
  • Grows in the cells that line back of throat and lungs
  • Virus spread via respiratory route
  • Easily transmitted and highly infectious
  • In the absence of vaccine-induced immunity, virtually every child can be expected to develop measles if the virus is circulating in the community
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Measles: Transmission

A
  • Spread by coughing and sneezing
  • Close personal contact
  • Direct contact with infected nasal or throat secretions
  • Virus remains active and contagious in the air or on infected surfaces for up to 2 hours
  • Can be transmitted by an infected person from 4 days prior to onset of rash to 4 days after rash erupts
17
Q

Measles: Symptoms

A
  • Fever – begins ~ 10-12 days after exposure and last 4-7 days
  • Cough
  • Runny noes
  • Red and watery eyes
  • Malaise
  • Small white spots inside the cheeks
  • Early phase indistinguishable from other viral respiratory infections (first several days when most contagious)
  • Characteristic rash appears after 7 to 14 days and spreads over 3 days, eventually to hands and feet
  • Rash lasts 5-6 days, then fades
18
Q

Measles: Complication

A

Common: pneumonia, diarrhea, ear infection
Less Common: encephalitis, blindness

Measles in pregnancy: Higher risk for severe complication, Pregnancy may end in miscarriage or preterm delivery

Risk Factors: Younger age, Malnutrition (particularly vitamin A deficiency), HIV infection

Measles frequently leaves a child weakened and at increased risk of illness and death from other causes for a year or more after the acute episode

19
Q

Measles: Treatment

A
  • Supportive care to avoid complications
  • Good nutrition
  • Adequate fluid intake
  • Treatment of dehydration
  • Antibiotics for secondary infections
  • 2 doses of vitamin A supplements, given 24 hours apart (shown to reduce deaths by 50%)
20
Q

Measles: Epidemiology

A

-One of the leading causes of death among young children even though a safe and cost-effective vaccine is available
-Most mortality in children < 5
> 95% of measles deaths occur in low-income countries with weak health infrastructures
-Measles vaccination resulted in a 71% drop in measles deaths 200 – 2011 worldwide
-2011 about 84% of the world’s children received one dose of measles vaccine by their first birthday through routine health services
-Unvaccinated children are at highest risk
-Unvaccinated pregnant women also at risk
-Any non-immune person can become infected
-Still common in many developing countries, especially Africa and Asia
> 20 million affected each year

21
Q

Measles deaths in 2011

A

158,000 globally
~ 430 deaths every day
~18 deaths every hour
-Over 95% in countries with low per capita incomes and weal health infrastructures
-Outbreaks particularly deadly in countries experiencing or recovering from natural disaster or conflict due to:
-Damaged health infrastructure/interrupted immunization programs
-Overcrowding in residential camps

22
Q

Measles: Prevention

A
  • Routine vaccination of children
  • Mass immunization campaigns in countries with high case and death rates
  • Often incorporated with rubella and/or mumps vaccines

-Barriers to eradication: Widespread disease, Often occurs in infants prior to age of first vaccination

23
Q

Diphtheria

A
  • Caused by bacterium Coryne-bacterium diphtheriae
  • Spread via respiratory route
  • Toxin mediated
  • In low- and middle-income countries can also cause (and be spread via) ulcerative skin lesions
  • Complications: Infection of the nasopharynx that may cause breathing difficulties and death
24
Q

Diphtheria: Treatment

A
  • Antibiotics: Erythromycin or penicillin for 14 days and post treatment cultures to confirm eradication
  • Diphtheria antitoxin (rarely available in low- and middle-income countries
  • Treatment recommended for patients with active disease and all close contacts
  • Mortality rate 5-10% , > 20% in children under 5 and adults over 40
25
Q

Diphtheria: Epidemiology

A
  • Primarily a disease of childhood (< 12 years old)
  • Infants become susceptible at age 6-12 months after transplacentally derived immunity wanes
  • Recently shifted into adolescent and adult population (> 40) primarily due to incomplete immunization status
26
Q

Diphtheria: 2011 global figures

A
  • 4,887 reported cases
  • Likely under diagnosed
  • 83% estimated DTP3 coverage
  • 24% of countries reached > 80% DTP3 coverage in all districts
  • Because vaccination does not lead to elimination of carriage of C. diphtheriae from the nasopharynx, ongoing control requires high levels of vaccine coverage
27
Q

Pertussis (Whooping Cough)

A
  • Caused by bacterium Bordetella pertussis
  • Spread via respiratory route
  • Highly contagious
  • Significant cause of morbidity and mortality in absence of high levels of coverage with vaccine
  • Difficulty to distinguish from other respiratory infections
28
Q

Pertussis (Whooping Cough): symptoms

A
  • Incubation period of 6-20 days (usually 9-10)
  • Followed by URI symptoms with cough
  • After 1-2 weeks coughing paroxysms ending in characteristic whoop may develop
  • Treatment may not be effective once symptoms develop
29
Q

Tetanus

A
  • Caused by anaerobic bacterium Clostridium tetanus
  • Commonly found in GI tract of many domesticated animals (cows, sheep, and goats)
  • Spores can remain viable for years-decades when deposited in soil
  • When spores introduced into wound or other suitable environment they produce highly toxic neurotoxins as they grow
30
Q

Tetanus: symptoms 7 treatments

A
  • Painful stiffening and spasms of muscles (including jaw)
  • Results in inability to suck or otherwise feed (particularly in newborn infants)

Tx: Supportive: -Muscle relaxants -IV fluids

Fatality rate very high: 80% to 90% in infants and newborns

31
Q

Tetanus: Epidemiology

A
  • In 1970s and 1980s 60/1,000 (6%) were developing neonatal tetanus in some low-income countries
  • Primarily due to contamination of the umbilical stump
  • Virtually all died
  • Deaths due to neonatal tetanus accounted for ¼ - ¾ of all neonatal deaths and as much as ¼ of all infant mortality in these countries
32
Q

Cholera

A
  • Acute diarrheal disease that can kill within hours if left untreated
  • Caused by ingestion of food or water contaminated with the bacterium Vibrio cholerae
  • Incubation period – 2 hours to 5 days
  • Extremely virulent in both children and adults
  • Bacteria present in feces for 7-14 days after infection (even if asymptomatic)
33
Q

Vibro Cholerae strains

A
  • 01 and 0139 cause outbreaks
  • 01 causes majority of outbreaks
  • 0139 confined to South-East Asia
  • Non-01 and non-0139 can cause mild diarrhea but do not generate epidemics
  • New variant strains have been detected in parts of Asia and Africa
  • New strains may cause more severe disease with higher fatality rates
34
Q

Cholera: symptoms

A

~75% have no symptoms
-Among people with symptoms, 80% have mild or moderate symptoms
~20% develop acute watery diarrhea with severe dehydration

35
Q

Cholera: Risk factors

A
  • Low immunity
  • Malnutrition
  • Inadequate environmental management
  • Peri-urban slums where basic infrastructure is not available
  • Camps for internally displace people or refugees
  • Consequence of disaster with disruption of water and sanitation systems
36
Q

Cholera: Epidemiology

A
  • Pandemics during 19th century killed millions of people across all continents
  • Current pandemic started in South Asia in 1961
  • Reached Africa in 1971
  • Reached the Americas in 1991
  • Now endemic in many countries
37
Q

Cholera: Prevention and control

A
  • Easily treatable
  • Up to 80% can be treated successfully through prompt oral rehydration salts
  • IV fluids for severe dehydration
  • Appropriate antibiotics to diminish duration of diarrhea in severe cases
  • Mass administration of antibiotics not recommended
  • Important to ensure prompt access to treatment
  • Safe water
  • Proper sanitation
  • Health education for improved hygiene
  • Safe food handling
38
Q

Oral cholera vaccines

A
  • Two types of safe and effective oral cholera vaccines currently available
  • Both have sustained protection of over 50% lasting for 2 years in endemic settings
  • Both administered in 2 doses given between 7 days and 6 weeks apart
  • WHO recommends vaccines in conjunction with control measures in endemic areas as well as areas at risk of outbreaks